8-K: OpGen Inc. Faces Delisting from Nasdaq Despite Regaining Compliance, Plans Relisting

OpGen Inc. will be delisted from the Nasdaq Capital Market after the Nasdaq Listing Council upheld a previous decision, despite the company briefly regaining compliance with minimum stockholders' equity requirements.

Summary

• OpGen, Inc. received notice that the Nasdaq Listing Council affirmed the decision to delist the company's securities.
• This decision comes despite OpGen regaining short-term compliance with the minimum stockholders' equity requirement.
• The delisting was initially triggered by the company's failure to meet the minimum stockholders' equity requirement.
• OpGen had appealed the initial delisting decision, but the appeal was unsuccessful.
• The company's shares will now trade on the OTC Markets under the symbol OPGN.
• OpGen plans to apply for relisting on Nasdaq after meeting the necessary requirements.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting from Nasdaq, despite the company's intention to relist. This event typically leads to decreased investor confidence and potential difficulties in raising capital.

Positives

• OpGen regained short-term compliance with the minimum stockholders' equity requirement before the delisting decision was affirmed.
• The company plans to apply for relisting on Nasdaq after meeting the relevant requirements.

Negatives

• OpGen failed to maintain the minimum stockholders' equity requirement for continued listing on Nasdaq.
• The Nasdaq Listing Council affirmed the decision to delist the company's securities.
• The company's shares will now trade on the OTC Markets, which may have lower liquidity and visibility.

Risks

• The company may not be able to successfully relist its securities on Nasdaq.
• Trading on the OTC Markets may result in lower liquidity and reduced investor interest.
• The delisting could negatively impact the company's ability to raise capital in the future.

Future Outlook

OpGen plans to apply for relisting on Nasdaq after meeting the relevant listing requirements, but there is no guarantee of success.

Management Comments

• The Company continues to disagree with the Listing Council's decision.
• The Company plans to apply for relisting with The Nasdaq Stock Market LLC after meeting the relevant Nasdaq listing requirements.

Industry Context

Delistings from major exchanges can negatively impact a company's valuation and investor confidence, often leading to increased volatility and reduced access to capital. This is a common issue for companies that struggle to maintain listing requirements.

Comparison to Industry Standards

• Companies like Agenus Inc. (AGEN) and Diffusion Pharmaceuticals Inc. (DFFN) have also faced delisting notices from Nasdaq due to similar issues with minimum stockholders' equity.
• The process of relisting on Nasdaq typically involves demonstrating sustained compliance with listing requirements, which can be challenging and time-consuming.
• Compared to companies that successfully maintain their Nasdaq listing, OpGen's situation highlights the risks associated with financial instability and non-compliance.

Stakeholder Impact

• Shareholders will experience a change in trading venue from Nasdaq to the OTC Markets.
• The delisting may negatively impact investor confidence and the company's valuation.
• Employees may experience uncertainty due to the company's financial challenges.

Next Steps

• OpGen will file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission.
• The company's shares will begin trading on the OTC Markets under the symbol OPGN.
• OpGen plans to apply for relisting on Nasdaq after meeting the relevant listing requirements.

Key Dates

Keywords

delisting, Nasdaq, stockholders' equity, OTC Markets, relisting, OPGN, compliance